Showing results (5491-5500 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|February 1, 2023
Managing Ibrutinib-Intolerant Patients With B-Cell MalignanciesJavier Muñoz, Shayna Sarosiek, Jorge J Castillo
The Oncologist|February 1, 2023
Outcome of Patients With Malignant Peripheral Nerve Sheath Tumors Enrolled on Sarcoma Alliance for Research Through Collaboration (SARC) Phase II TrialsSrivandana Akshintala, Nicole C Mallory, Yao Lu, et al.
The Oncologist|February 1, 2023
Prevalence and Associations of Beta2-Microglobulin Mutations in MSI-H/dMMR CancersFangcen Liu, Fangfang Zhong, Huan Wu, et al.
The Oncologist|February 6, 2023
Decision-Making and Health-Related Quality of Life in Patients with Melanoma Considering Adjuvant ImmunotherapyThomas M Atkinson, Jennifer L Hay, Soo Young Kim, et al.
The Oncologist|February 27, 2023
Implementation of Precision Oncology in Clinical Practice: Results of a National Survey for Health Care ProfessionalsGianpiero Fasola, Maria C Barducci, Giacomo Pelizzari, et al.
The Oncologist|March 23, 2023
Phase I Trial of Combination Therapy With Avelumab and Cabozantinib in Patients With Newly Diagnosed Metastatic Clear Cell Renal Cell CarcinomaHaoran Li, Kamal Kant Sahu, James Brundage, et al.
The Oncologist|August 16, 2021
Results with Floxuridine, Actinomycin D, Etoposide, and Vincristine in Gestational Trophoblastic Neoplasias with International Federation of Gynecology and Obstetrics Scores ≥5Yuan Li, Yujia Kong, Xirun Wan, et al.
The Oncologist|August 19, 2021
Knowledge About Risks, Benefits, and Curative Potential of Immunotherapy Among Patients with Advanced CancerLaura A Petrillo, Ashley Z Zhou, Ryan Sullivan, et al.
The Oncologist|August 13, 2022
Adherence to the Dutch Breast Cancer Guidelines for Surveillance in Breast Cancer Survivors: Real-World Data from a Pooled Multicenter AnalysisTeresa Draeger, Vinzenz Voelkel, Kay Schreuder, et al.
The Oncologist|December 3, 2025
NCI 10211: a phase II, single-arm study of berzosertib in combination with irinotecan in patients with advanced TP53 mutant gastroesophageal cancerMargaret C Wheless, Shannon Stockton, Heloisa P Soares, et al.
Pageof 571